Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject for RLS in Pregnancy
NCT01245777Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Oct 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric carboxymaltose in restless legs syndrome (RLS) and iron deficiency anemia (IDA), sponsored by University of Zurich. Primary endpoint: International Restless Legs Syndrome Study Group rating scale reduction at 60 days. Started Oct 2009; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
restless legs syndrome (RLS)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01245777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245777.